The study of Fiandaca et al. (2015) revealed that the exosomal levels of P-S396-tau, P-T181-tau and Aβ1-42 were significantly higher than in controls at one to 10 years prior to diagnosis with Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.